index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Centronuclear myopathy Becker muscular dystrophy Cell Line Mdx mouse DMO Dystrophie Musculaire de Duchenne DMD Liver Calcium Cardiomyopathie NNOS L-Type Diseases Dystrophin Cell Biology Gene modifiers Morphogenesis Base Sequence Multi resolution modeling Hear CD38 Molecular docking Calcium Channels Allele‐specific silencing therapy Mice Long QT Male Cell homeostasis Activin Receptors Inbred mdx Myotendinous junction Muscular Atrophy MES Cardiomyopathy Humans Myogenesis Muscles/physiopathology Multiresolution modeling Mitochondrial fission Clinical trials CaVβs Dystrophy Delivery Modificateurs de gènes CTNNB1 Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Skeletal muscle CaV subunits Muscle Biology Muscle Drp1 Epigenetics Dynamin 2 Homeostasis Dystrophin-EGFP Cells Duchenne muscular dystrophy DMD Gene expression Human Umbilical Vein Endothelial Cells Hepatocellular carcinoma Inbred C57BL Dystrophie Musculaire de Becker BMD LKB1 Duchenne DMD dystrophy Invivo Antisense oligonucleotides Génomique Animals Dystrophin central domain Becker BMD muscular dystrophy Exon skipping LncRNA Dystrophie musculaire de Becker Knockout MiARN Ex-vivo Inhibitors Duchenne muscular dystrophy Genomic Gene Expression Regulation/drug effects Dystrophine Muscular Dystrophy Cultured Animal/physiopathology Muscle development DHPR α1S LncARN NAD+ Cachexia Multi exon skipping Metabolism Energy Metabolism/drug effects Long noncoding RNA Becker muscular dystrophy BMD Muscle Strength Molecular Sequence Data Muscular dystrophy DMD BMD Immunoglobulin Fc Fragments/pharmacology Autophagy